Inventiva announces the presentation of five scientific abstracts at the AASLD The Liver Meeting™ 2021

NEXT STORY
Paratek Pharmaceuticals Announces Enrollment of First Patient in Phase 2b Study Evaluating NUZYRA® (omadacycline) for Nontuberculous Mycobacterial (NTM) Pulmonary Disease Caused by Mycobacterium abscessus Complex (MABc)
PREV STORY
New to The Street TV Announces its Five Corporate Interviews Airing on Fox Business Network, Tonight, Monday, October 18, 2021, at 10:30 PM P.T. and Tomorrow Night, Tuesday, October 19, 2021, at 10:30 PM PT
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Innovation Pharmaceuticals Granted Regulatory Approval to Start Phase 1 Trial of Oral Brilacidin in Ulcerative Colitis Program; Company Aims to Capture Large Market Opportunity for Novel Oral IBD Drug Candidates

author_avatar
NASDAQ Market News

Predictive Oncology and Dr. Daniel Carter Collaborating to Develop a Potential COVID-19 Vaccine Utilizing Novel Nanoparticle Vaccine Platform, Based on NSP-10

author_avatar
NASDAQ Market News

Galena Biopharma Announces Pricing of Public Offering of Common Stock and Warrants

SAN RAMON, Calif., Feb. 08, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a ...

author_avatar
NASDAQ Market News